# pyrimethamine

### notes
+ prescription under medical supervision

### therapeutic action
+ antiprotozoal

### indications
+ treatment and secondary prophylaxis of toxoplasmosis in immunodeficient patients, in combination with sulfadiazine or clindamycin
+ primary prophylaxis of toxoplasmosis in immunodeficient patients, in combination with dapsone (only if cotrimoxazole cannot be used)
+ second-line treatment of isosporiasis in immunodeficient patients (only if cotrimoxazole cannot be used)

### presentation
+ 25 mg tablet

### dosage and duration
+ treatment of toxoplasmosis
adult: 200 mg in 2 divided doses on the first day, then 75 to 100 mg/day for at least 6 weeks
+ secondary prophylaxis of toxoplasmosis
adult: 25 to 50 mg/day, as long as necessary
+ primary prophylaxis of toxoplasmosis
adult: 50 to 75 mg/week, as long as necessary
+ treatment of isosporiasis
adult: 50 to 75 mg/day for 10 days

### contra-indications, adverse effects, precautions
+ do not administer to patients with severe renal or hepatic impairment.
+ may cause: gastrointestinal disturbances, seizures, leucopenia, thrombocytopenia, megaloblastic
anaemia due to folinic acid deficiency.
+ administer calcium folinate to prevent folinic acid deficiency.
+ avoid if possible combination with other folate antagonists: cotrimoxazole, methotrexate (increased risk of folinic acid deficiency).
+ monitor combination with zidovudine (increased risk of zidovudine-associated haematotoxicity).
+ *pregnancy*: contra-indicated during the first trimester
+ *breast-feeding*: no contra-indication; however avoid concomitant administration of other folate
antagonists.

### remarks
+ the combination of sulfadoxine/pyrimethmine is used for the treatment of uncomplicated falciparum
malaria.
+ storage: below 25Â°c

